Skip to main content
Clinical Trials/NL-OMON43599
NL-OMON43599
Completed
Not Applicable

A cross-sectional study to assess night-shift work related exposures and their association with markers of biological perturbation - CLOCKWORK

niversiteit Utrecht0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biomarkers, circadian and biological disruption markers
Sponsor
niversiteit Utrecht
Enrollment
300
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Subject is between 18 years and 65 years of age by the time of performing the screening questionnaire.
  • \- Subjects are female.
  • \- Subjects are nurse or employed in a paramedic profession.
  • \- Subjects either have not worked in a profession requiring shift work for over 5 years, just started working in night shifts (\<2 year) or worked in night\-shifts for over 5 years.
  • \- Subjects are willing to give blood, fill out the questionnaires, and wear the sensors.;For the sub\-study the same inclusion criteria apply with the exception of the last one. This criterion is replaced with:
  • \- Subjects are willing to give blood and fill out the questionnaires.

Exclusion Criteria

  • \- Subject is a smoker or ex\-smoker for less than 6 months since baseline of study inclusion. Occasional smokers that have smoked less than 100 cigarettes in their lifetime are considered non\-smokers.
  • \- Subject has a doctor diagnosed chronic disease/disorder (i.e. CVD, metabolic syndrome, diabetes).
  • \- Subject has/had cancer excluding non\-melanoma skin cancer.
  • \- Subject uses beta\-blockers, or melatonin supplementation.
  • \- Subject was pregnant in the last 6 months or is planning to become pregnant in the next 12 months.
  • \- Subject is in fertility treatment.;Exclusion criteria for the sub\-study are the same

Outcomes

Primary Outcomes

Not specified

Similar Trials